Drug Database
BE

benzoyl peroxide (Exact)

✓ Approved

Teva Pharmaceutical Industries Ltd. · 小分子 · 小分子

什么是 benzoyl peroxide?

benzoyl peroxide 是一种小分子,由Teva Pharmaceutical Industries Ltd.研发。该药已获批,用于治疗相关适应症,给药途径:Topical。

药物档案

商品名Exact
公司Teva Pharmaceutical Industries Ltd.
药物类别小分子
给药途径Topical
状态Approved

治疗适应症

benzoyl peroxide 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Skin and subcutaneous tissue disordersAcne✓ Approved

相关研究文献

PubMedJournal of the American Chemical Society2026-11-19

A Mixed Conducting Polymer with pH-Dependent Selectivity for the Oxygen Reduction Reaction.

de la Fuente Durán Ana A, Penn Emily E, Marks Adam A, Siemons Nicholas N et al.

Achieving 4-electron oxygen reduction with metal-free electrodes has remained a longstanding challenge. Here, we show that poly(benzimidazobenzophenanthroline) (BBL), an n-type ladder polymer, breaks this barrier through an electrocatalytic inner-sphere 2 + 2 series mechanism─a mode of reactivity unprecedented among organic mixed ionic-electronic conductors (OMIECs). Using pH-dependent rotating ring-disk voltammetry, we find that this series mechanism occurs over separate potential windows on BBL. At more positive potentials, an initial reduction wave correlated with electron polaron formation in BBL produces exclusively hydro(gen) peroxide across all pH values, followed by a second, pH-dependent wave for hydro(gen) peroxide reduction at more negative potentials. At pH 14.0, this second wave enables complete four-electron reduction of O2 (n ≈ 4) to OH-, driven by formation of a bipolaronic state in BBL. Decreasing the pH instead stabilizes a hydrogenated state in BBL incapable of O-O bond cleavage, reverting selectivity to n ≈ 2. These insights reveal that the coupling between ion selectivity during electrochemical ion-insertion and product selectivity during ORR catalysis shapes active-site structure and poisoning, establishing a new design principle in the emerging field of OMIEC electrocatalysis.

PMID 43053457
阅读全文 →
PubMedJournal of advanced nursing2026-11-19

Economic Evaluations of Advanced Practice Nursing in the Management of Non-Communicable Diseases: A Systematic Review.

Dadjo Lokossou Marie-Rose MR, Giraud Victorien V, Gelle Thibaut T, Beloni Pascale P et al.

To evaluate the economic value of advanced practice nursing in the management of non-communicable diseases. Systematic review without meta-analysis. Six databases were searched. Title/abstract and full-text screening, and data extraction were performed independently by two reviewers, with disagreements resolved by a third reviewer. Risk of bias was assessed using RoB 2.0 and ROBINS-I; economic reporting quality was assessed using CHEERS 2022. Certainty of evidence was rated using GRADE. PubMed, Scopus, Web of Science, CINAHL, Cochrane Library and EconLit searched from 2012 to March 2026. Twenty studies published between 2012 and 2025 were included, most reporting favourable economic outcomes to advanced practice nursing, although results varied by economic perspective and time horizon. Advanced practice nursing is a clinically effective and economically efficient response to the growing burden of non-communicable diseases, despite heterogeneous results and limited evidence from low- and middle-income countries. Advanced practice nursing offers an efficient response to chronic disease management, supporting its wider implementation, particularly in under-resourced settings. This review addresses the lack of up-to-date evidence on the economic efficiency of advanced practice nursing in chronic disease management. Efficiency was generally favourable but context-sensitive, with implications for nursing workforce planning and health policy. PRISMA 2020, supplemented by Synthesis Without Meta-analysis guidance. No patient or public contribution. PROSPERO: CRD420261336116.

PMID 43053485
阅读全文 →
PubMedCancer research communications2026-11-19

Nerve proximity and high endothelial venules mark tertiary lymphoid structure niches associated with survival in advanced pancreatic cancer: an autopsy study.

Jacobsen Hedda H, Svensson Maja M, Briem Oscar O, Lehn Sophie S et al.

Tertiary lymphoid structures (TLSs) are generally associated with favorable outcomes in treatment-naïve pancreatic cancer, but their relevance in advanced disease remains unclear. Here, we investigated TLS prevalence and histological features in advanced pancreatic/periampullary cancer in a research autopsy cohort. Primary and metastatic tumor tissue from 19 patients was screened for TLSs using histology, duplex immunohistochemistry, and multiplex immunofluorescence. TLSs were classified by maturation stage, high endothelial venule (HEV) presence and proximity to nerves. Associations with tissue site, chemotherapy exposure, and overall survival (OS) were analyzed. Across 480 postmortem tumor blocks, 279 TLSs were identified in 38 TLS-positive blocks, predominantly from primary tumors. TLSs were more abundant and larger in primary tumors than in metastases. Only early TLSs and primary follicle-like TLSs were observed; no secondary follicle-like TLSs. TLS counts or size were not associated with OS. TLSs containing HEVs were, on average, larger than HEV-negative TLSs and tended to associate with prolonged OS, in particular in metastatic niches. Moreover, TLSs located in proximity to nerves were positively associated with OS, and the number of nerve-associated TLSs correlated with survival. Notably, the number of nerve-associated TLSs was also positively associated with the number of HEV-containing TLSs. Collectively, the findings from this exploratory study indicate that TLSs in advanced pancreatic cancer are heterogeneous and predominantly immature, with limited prognostic value based on TLS counts alone. Instead, specific microenvironmental features, particularly nerve proximity, may more accurately capture clinically relevant aspects of TLS biology in advanced disease.

PMID 43053676
阅读全文 →
PubMedThe Australasian journal of dermatology2026-11-19

Immune Checkpoint Inhibitor Therapy in Solid Organ Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma: A Narrative Review.

Jiang Jacqueline J, Chong Alvin H AH, McLean Luke S LS

Cutaneous squamous cell carcinoma (cSCC) is a leading cause of cancer-related morbidity and mortality in solid organ transplant recipients (SOTRs). Immune checkpoint inhibitors (ICIs) targeting programmed death receptor-1 (PD-1) have transformed the management of advanced cSCC, but SOTRs were excluded from the pivotal registrational trials. Early evidence of ICIs in this population was confined to retrospective studies, in which allograft rejection occurred in up to 42% of patients. However, retrospective studies were confounded by variable practice with immunosuppression regimes and concurrent ICI administration, both of which could independently contribute to rejection. This review synthesises the retrospective literature, the prospective trials designed to identify a protocol for ICI use in SOTRs with advanced cSCC, and contextualises the implications to clinical practice. While there remains a paucity of prospective trial data, two approaches show promise for preserving ICI-mediated anti-tumour efficacy with lower rejection rates than reported in retrospective studies. The current evidence supports consideration of ICIs in kidney transplant recipients with advanced cSCC with multidisciplinary input from dermatology, medical oncology and transplant physicians. Decision-making should account for tumour stage, prior therapy, immunological risk profile and patient preferences, with pre-treatment counselling regarding the risks and benefits, and contingency planning for dialysis in the event of allograft loss.

PMID 43053489
阅读全文 →
PubMedBMC nursing2026-11-19

Application of the hierarchical nursing model based on Snyder's hope theory in patients with advanced colorectal cancer undergoing chemotherapy.

He Tingting T, Chen Xue X, Fang Xiu-Fei XF

Patients with advanced colorectal cancer undergoing chemotherapy face significant physical and emotional challenges. Addressing their psychological needs is crucial for improving their quality of life. Snyder's Hope Theory, focusing on the role of hope in coping, offers a framework for enhancing nursing care. This study investigates the use of a hierarchical nursing model based on this theory to improve patient coping strategies and hope levels. 200 patients with advanced colorectal cancer undergoing chemotherapy at our center from July 2022 to July 2023 were included and randomly divided into a control group (n = 100) and an observation group (n = 100). The control group received routine nursing intervention for advanced colorectal cancer chemotherapy and routine guidance before and after chemotherapy. The observation group implemented a hierarchical nursing model based on Snyder's hope theory. The medical coping questionnaire (MCMQ) and Herth Hope Index (HHI) scores of patients in both groups before and after intervention were compared. Before the intervention, there was no statistically significant difference in MCMQ and HHI scores between the two groups (P > 0.05). After 6 cycles of chemotherapy, the observation group had higher scores in the face dimension and lower scores in the surrender and avoidance dimensions compared to the control group, with statistically significant differences (P < 0.05); the observation group had higher HHI scores than the control group, with statistically significant differences (P < 0.05). The hierarchical nursing model based on Snyder's hope theory can effectively improve the disease-coping strategies of patients with advanced colorectal cancer undergoing chemotherapy and increase their hope level, which is worthy of clinical promotion and application.

PMID 43052961
阅读全文 →
PubMedBMC cancer2026-11-19

Efficacy and safety of [¹⁷⁷Lu]Lu-DOTA-TATE versus standard systemic therapies in advanced well-differentiated gastroenteropancreatic neuroendocrine tumors: a retrospective cohort study.

Zhao Shuqiang S, Kou Shufang S

Advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs) present a therapeutic challenge due to their heterogeneity and variable response to systemic therapies. This study aimed to evaluate the real-world efficacy and safety of peptide receptor radionuclide therapy (PRRT) with [¹⁷⁷Lu]Lu-DOTA-TATE in patients with advanced well-differentiated GEP-NETs. This retrospective cohort study included 129 patients diagnosed with advanced well-differentiated GEP-NETs between January 2022 and December 2025. Patients were classified into two groups according to treatment strategy: the [¹⁷⁷Lu]Lu-DOTA-TATE group (n = 65) and the control group (n = 64), who received standard systemic therapies without PRRT. The primary endpoints were overall survival (OS) and progression-free survival (PFS). Secondary outcomes included objective response rate (ORR), disease control rate (DCR), and treatment-related adverse events. Prognostic factors for OS and PFS were evaluated using Cox regression analyses. The median duration of follow-up was 34.6 months (1.3-45.7) in the [¹⁷⁷Lu]Lu-DOTA-TATE group and 25.8 months (0.9-45.6) in the control group. The [¹⁷⁷Lu]Lu-DOTA-TATE group demonstrated significantly longer median OS (34.6 vs. 25.8 months; P = 0.046) and median PFS (22.0 vs. 16.7 months; P = 0.008) compared with the control group. ORR showed a trend toward improvement (P = 0.118), while DCR was significantly higher in the [¹⁷⁷Lu]Lu-DOTA-TATE group (P = 0.026). The overall incidence of adverse events and the rates of grade ≥ 3 adverse events were comparable between groups (P > 0.05). Multivariable analysis identified [¹⁷⁷Lu]Lu-DOTA-TATE treatment, younger age, lower Ki-67 index, and lower tumor grade as independent predictors of improved OS or PFS. [¹⁷⁷Lu]Lu-DOTA-TATE provides meaningful survival benefits with acceptable safety in patients with advanced well-differentiated GEP-NETs, supporting its integration into real-world treatment strategies and warranting further prospective validation.

PMID 43052866
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多benzoyl peroxide